1. Home
  2. GDC vs CELU Comparison

GDC vs CELU Comparison

Compare GDC & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDC
  • CELU
  • Stock Information
  • Founded
  • GDC 2015
  • CELU 2016
  • Country
  • GDC United States
  • CELU United States
  • Employees
  • GDC N/A
  • CELU N/A
  • Industry
  • GDC Steel/Iron Ore
  • CELU Biotechnology: Pharmaceutical Preparations
  • Sector
  • GDC Industrials
  • CELU Health Care
  • Exchange
  • GDC Nasdaq
  • CELU Nasdaq
  • Market Cap
  • GDC 65.3M
  • CELU 64.3M
  • IPO Year
  • GDC N/A
  • CELU N/A
  • Fundamental
  • Price
  • GDC $7.70
  • CELU $2.15
  • Analyst Decision
  • GDC
  • CELU Strong Buy
  • Analyst Count
  • GDC 0
  • CELU 1
  • Target Price
  • GDC N/A
  • CELU $6.00
  • AVG Volume (30 Days)
  • GDC 189.4K
  • CELU 136.2K
  • Earning Date
  • GDC 11-13-2025
  • CELU 08-29-2025
  • Dividend Yield
  • GDC N/A
  • CELU N/A
  • EPS Growth
  • GDC N/A
  • CELU N/A
  • EPS
  • GDC N/A
  • CELU N/A
  • Revenue
  • GDC N/A
  • CELU $44,590,000.00
  • Revenue This Year
  • GDC N/A
  • CELU N/A
  • Revenue Next Year
  • GDC N/A
  • CELU $76.00
  • P/E Ratio
  • GDC N/A
  • CELU N/A
  • Revenue Growth
  • GDC N/A
  • CELU 4.45
  • 52 Week Low
  • GDC $1.03
  • CELU $1.00
  • 52 Week High
  • GDC $9.92
  • CELU $5.22
  • Technical
  • Relative Strength Index (RSI)
  • GDC 65.90
  • CELU 34.61
  • Support Level
  • GDC $6.50
  • CELU $2.05
  • Resistance Level
  • GDC $9.92
  • CELU $2.41
  • Average True Range (ATR)
  • GDC 0.93
  • CELU 0.30
  • MACD
  • GDC 0.40
  • CELU -0.10
  • Stochastic Oscillator
  • GDC 63.90
  • CELU 6.57

About GDC GD Culture Group Limited

GD Culture Group Ltd focuses its business on two segments mainly through the Company and two subsidiaries. 1) AI-driven digital human creation and customization; 2) Live streaming and e-commerce. The company has relentlessly been focusing on serving its customers and creating value for them through the continual innovation and optimization of its products and services. For the AI-driven digital human creation and customization sector, the Company uses AI algorithms and software to generate realistic 3D or 2D digital human models. AI algorithms and machine learning models are used to simulate human characteristics, such as facial expressions, body movements, and even speech patterns.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: